#news #biotech Bladder cancer readout sees Nektar shares hit

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bladder cancer readout sees Nektar shares hit .Nektar has had a mixed few months as data fed through for its lead cancer drug NKTR-214, but new data in bladder cancer should help steady the ship.

from FierceBiotech: Biotech http://bit.ly/2GCdgb6